⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11260691 | 0.97 | — | — | |
| SCHEMBL11226772 | 0.75 | — | — | |
| SCHEMBL11094464 | 0.75 | — | — | |
| SCHEMBL9671218 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL11243494 | 0.75 | CYP2D6 (0.33) | — | |
| SCHEMBL7525656 | 0.73 | CYP2D6 (0.41) | — | |
| SCHEMBL612192 | 0.73 | — | — | |
| SCHEMBL28719441 | 0.73 | CYP2D6 (0.41) | — | |
| SCHEMBL42490 | 0.73 | — | — | |
| SCHEMBL5353897 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115873020-A | RAS inhibitors | 锐新医药公司 | 2023-03-31 | — | — | CN | claimed |
| CN-114901366-A | RAS inhibitors | 锐新医药公司 | 2022-08-12 | — | — | CN | claimed |
| EP-0315204-A2 | Bleaching composition | LION CORPORATION (JP) | 1989-05-10 | — | — | EP | claimed |
| EP-0004334-B1 | CARBAMATES AND THEIR PESTICIDAL COMPOSITIONS, PREPARATIONS THEREOF AND USE THEREOF AS PESTICIDES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-10-21 | — | — | EP | claimed |
| US-20260078098-A1 | PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES | SUPERNUS PHARMACEUTICALS, INC. (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4493550-A1 | PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES | Supernus Pharmaceuticals, Inc. (US) | 2025-01-22 | — | — | EP | disclosed |
| CN-118955384-A | Castor oil-based ionic liquid and preparation and application thereof | 贵州大学 | 2024-11-15 | — | — | CN | disclosed |
| CN-118843483-A | Method for supplementing antimicrobial biphasic polymers | HRL实验室有限责任公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-118451064-A | Process for preparing derivatives of substituted morpholines | 苏佩努斯制药公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-118019742-A | Novel benzodiazepine derivatives as GABA Aγ1 PAM | 豪夫迈·罗氏有限公司 | 2024-05-10 | — | — | CN | disclosed |
| US-11964951-B2 | Process of making derivatives of substituted morpholines | SUPERNUS PHARMACEUTICALS, INC. (US) | 2024-04-23 | — | — | US | disclosed |
| CN-117813357-A | Phase separated antimicrobial coatings and methods of making and using the same | HRL实验室有限责任公司 | 2024-04-02 | — | — | CN | disclosed |
| US-5268468-A | Or optical isomers thereof | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-12-07 | — | — | US | disclosed |
| US-5268468-A | Or optical isomers thereof | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-12-07 | — | — | US | disclosed |
| US-5229417-A | Obsessive compulsive disorders | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-07-20 | — | — | US | disclosed |
| EP-0545425-A1 | 2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-06-09 | — | — | EP | disclosed |
| US-5114935-A | Antitussive agents | DR. KARL THOMAE GMBH (DE) | 1992-05-19 | — | — | US | disclosed |
| EP-0290313-B1 | PROCESS FOR OBTAINING ACTIVATED NITROSOCARBAMATES | SANOFI (FR) | 1992-03-04 | — | — | EP | disclosed |
| EP-0315204-A2 | Bleaching composition | LION CORPORATION (JP) | 1989-05-10 | — | — | EP | disclosed |
| EP-0290313-A1 | Process for obtaining activated nitrosocarbamates | SANOFI (FR) | 1988-11-09 | — | — | EP | disclosed |